Decitabine and platelet count decreased 
Decitabine and platelet count decreased Patient Reports February 12, 2012
Decitabine Side Effects Report #5724482-8
Decitabine side effect was reported by a Physician from ITALY on Apr 17, 2008. Male patient, 77 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: fatigue, neutropenia, platelet count decreased, pneumonitis, pyrexia. Decitabine dosage: 135MG/M2 PER COURSE, EVERY SIX WEEKS : 252 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5613386-7
Decitabine side effect was reported by a Physician from VENEZUELA on Jan 14, 2008. Female patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: necrotising fasciitis, platelet count decreased, red blood cell count decreased. Decitabine dosage: 15 MG/M2, 2 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5633774-2
Decitabine side effect was reported by a Physician from VENEZUELA on Feb 07, 2008. Female patient, 74 years of age, weighting 103.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, necrotising fasciitis, platelet count decreased, red blood cell count decreased, skin infection, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 2 IN 1 DAY, INTRAVENOUS; 20 MG/M2, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.
Decitabine Side Effects Report #5646197-7
Decitabine side effect was reported by a Physician from VENEZUELA on Feb 18, 2008. Female patient, 74 years of age, weighting 103.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, necrotising fasciitis, platelet count decreased, septic shock, skin infection, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 2 IN 1 DAY, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 02/15/2008.
Decitabine Side Effects Report #5717276-0
Decitabine side effect was reported by a Physician from VENEZUELA on Apr 17, 2008. Male patient, 73 years of age, weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cerebral haematoma, haematocrit increased, haemoglobin decreased, haemorrhagic stroke, hypertensive crisis, platelet count decreased. Decitabine dosage: 15 MG/M2, INTRAVENOUS. During the same period patient was treated with AVANDIA, DIAMICRON, FOLIC ACID, VITAMIN D, GABAPENTIN, LEVOTHYROXINE, ACETAMINOPHEN, ACYCLOVIR. Patient was hospitalized. Patient died on 02/23/2008.
Decitabine Side Effects Report #5449580-8
Decitabine side effect was reported by a Health Professional from ARGENTINA on Aug 28, 2007. Male patient, 68 years of age, weighting 176.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, hypotension, melaena, platelet count decreased, white blood cell count decreased. Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5924663-4
Decitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 30, 2008. Female patient, 62 years of age, weighting 143.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: body temperature increased, culture urine positive, gastritis haemorrhagic, neutropenia, platelet count decreased. Decitabine dosage: 33 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5839624-3
Decitabine side effect was reported by a Physician from MALAYSIA on Aug 01, 2008. Female patient, 59 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome, serum ferritin increased and was treated with Decitabine. After drug was administered, patient experienced the following side effects: enterobacter infection, haemoglobin decreased, neutrophil count decreased, pathogen resistance, platelet count decreased, skin infection, subcutaneous abscess. Decitabine dosage: 25 MG, INTRAVENOUS; 25 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5567421-5
Decitabine side effect was reported by a Physician from NETHERLANDS on Dec 05, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, tooth abscess, tooth extraction, ulcer
, white blood cell count decreased. Decitabine dosage: 15 MG/M2, 3 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5646198-9
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 18, 2008. Female patient was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: colitis, haematocrit decreased, hypotension, neutropenia, platelet count decreased, pyrexia, septic shock. Decitabine dosage: 29 MG, INTRAVENOUS. During the same period patient was treated with SODAMINT, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5940346-9
Decitabine side effect was reported by a Physician from SERBIA on Oct 23, 2008. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematemesis, haemoglobin decreased, ileus, platelet count decreased, white blood cell count decreased. Decitabine dosage: unknown. Patient died on 10/22/2008.
Decitabine Side Effects Report #5616220-4
Decitabine side effect was reported by a Physician from POLAND on Jan 22, 2008. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: cardiac arrest
, culture throat positive, haemoglobin decreased, moraxella infection, oesophagitis, oral candidiasis, platelet count decreased, white blood cell count decreased. Decitabine dosage: unknown. During the same period patient was treated with SPIRONOLACTONE. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5626139-0
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 31, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: abdominal tenderness, dysphonia, febrile neutropenia, haemoglobin decreased, odynophagia, platelet count decreased, tonsillitis, white blood cell count decreased. Decitabine dosage: 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with FELODIPINE, GLIPIZIDE, METFORMIN, MAGNESIUM OXIDE, SILYMARIN, SENNOSIDE A. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5652150-X
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 22, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: abdominal tenderness, febrile neutropenia, haemoglobin decreased, odynophagia, platelet count decreased, tonsillitis. Decitabine dosage: 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS; 20 MG/M2, 1 IN 1 DAY, INTRAVENOUS, 20 MG/M2, 1 IN 1 DAY, INTRAVEN. During the same period patient was treated with FELODIPINE, GLIPIZIDE, METFORMIN, MAGNESIUM OXIDE, SILYMARIN, SENNOSIDE A. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5572439-2
Decitabine side effect was reported by a Physician from AUSTRALIA on Dec 05, 2007. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: abdominal pain upper, haematemesis, haemoglobin decreased, hepatic steatosis, hepatomegaly, lower respiratory tract infection, neutrophil count decreased, platelet count decreased, pleural effusion. Decitabine dosage: 40 MG, IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5874118-0
Decitabine side effect was reported by a Physician from CZECH REPUBLIC on Aug 19, 2008. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumonitis. Decitabine dosage: 38 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, FLUCONAZOLE, AMOXICILLIN, AUGMENTIN. Patient was hospitalized. Patient recovered.
Decitabine Side Effects Report #5732084-2
Decitabine side effect was reported by a Health Professional from POLAND on Apr 29, 2008. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: genital herpes, haematocrit decreased, haemoglobin decreased, herpes simplex
, oedema peripheral, platelet count decreased, red blood cell count decreased, soft tissue inflammation, white blood cell count decreased. Decitabine dosage: 34.5 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with BENZYDAMINE HYDROCHLORIDE, TAZOBACTAM. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5846227-3
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 07, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, neutropenia, phlebitis, platelet count decreased, pyrexia, thrombosis, vasculitis
. Decitabine dosage: 31.2, MG, IN 1 DAY; INTRAVENOUS, 31.8 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Decitabine Side Effects Report #5442924-2
Decitabine side effect was reported by a Health Professional from CANADA on Aug 17, 2007. Female patient, 48 years of age, weighting 142.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: platelet count decreased, pulmonary embolism
. Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient recovered.Decitabine Side Effects Report #5732076-3
Decitabine side effect was reported by a Physician from GERMANY on Apr 29, 2008. Female patient, 76 years of age, weighting 209.4 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood calcium decreased, c-reactive protein increased, haematocrit decreased, haemoglobin decreased, international normalised ratio decreased, platelet count decreased, urinary bladder haemorrhage, white blood cell count decreased. Decitabine dosage: 297 MG,INTRAVENOUS. Patient was hospitalized. Patient died on 03/18/2007.
Decitabine Side Effects Report #5745888-7
Decitabine side effect was reported by a Physician from GERMANY on May 09, 2008. Male patient, 76 years of age, weighting 209.4 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: bladder tamponade, blood calcium decreased, coagulopathy, disseminated intravascular coagulation, haematocrit decreased, haemoglobin decreased, haemorrhage, platelet count decreased, urinary bladder haemorrhage. Decitabine dosage: 297 MG, INTRAVENOUS. During the same period patient was treated with COTRIM, ALLOPURINOL, HEXORAL, AMPHORONAL, LEVOFLOXACIN. Patient was hospitalized. Patient died on 03/18/2007.
Decitabine Side Effects Report #5657879-5
Decitabine side effect was reported by a Physician from TURKEY on Feb 22, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, disease progression, febrile neutropenia, fibrin d dimer increased, haemorrhage intracranial, liver function test abnormal, platelet count decreased, prothrombin time prolonged. Decitabine dosage: 225 MG, INTRAVENOUS. During the same period patient was treated with PIPERACILLIN TAZOBACTAM, AMIKACIN, PRIMAXIN, NETILMICIN SULPHATE, DEFEROXAMINE. Patient was hospitalized and became disabled. Patient died on 03/22/2007.